POM Stock Nears 12 Cents as Nasdaq Deadline for Pomdoctor Gets Focus
Pomdoctor Limited’s Nasdaq-listed ADSs fell to $0.1153 in early U.S. trading Thursday, down $0.0094 from the previous close, with 172,520 shares traded. The company remains below Nasdaq’s $1 minimum-bid requirement and has until July 28 to regain compliance. Pomdoctor recently reported a wider 2025 net loss despite higher revenue.
